*Human Pai 1 Recombinant Latent N Terminal Mutation

Select this product for Molecular Innovations name, N-Terminal Cys mutant (latent wild type) and product number, NTCYSPAI-L.Human PAI-1 Recombinant Latent N Terminal Mutation from Innovative Research has been recombinantly produced in E. coli and purified by affinity chromatography. This is a Frozen liquid buffered in 0.1M HEPES; 0.1M NaCl; 1mM DTT; pH 7.4 and a purity of >95% as determined by SDS-PAGE. More Details: Species: Human Target: PAI-1 Purification Method: Affinity purified Purity: >95% as determined by SDS-PAGE Analysis Source: E. coli Storage Conditions: -70 C Additional Information: Wild type PAI-1, cloned, with a cysteine residue at the N-terminus. The latent fraction is less than than 0.4% active. The protein is supplied in buffer with 1 mM DTT to prevent dimerization. This product can be used as a control in applications like ELISA and Western Blot. It can be used in a wide range of in vitro applications, including blocking/inhibition, fibrinolysis, plasminogen activation, receptor binding, in hypertension studies, for protein-protein interactions, and more. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.